• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Dupixent

A young woman hits a yellow-and-black soccer ball toward a stand printed with sanofis logo
Marketing

Sanofi teams up with Special Olympics Unified Football World Cup

Two years after its central role in the Paris Olympics in France, Sanofi is back in its home country once again supporting sport.
Ben Adams Jul 15, 2026 8:05am
Eylea

Regeneron sees more regulatory issues, sales declines for Eylea

Apr 29, 2026 12:05pm
Sanofi

Sanofi has 'vigorous defense planned' for Dupixent patent cliff

Apr 23, 2026 1:35pm
Eli Lillys Lilly Seaport Innovation Center in Boston

Lilly's Ebglyss scores eczema trial win in children

Mar 16, 2026 10:50am
gold arrow pointing upward forward

Galderma doubles Nemluvio peak sales outlook to $4B-plus

Mar 5, 2026 11:20am
Regeneron

Regeneron faces category headwinds for eye disease drug Eylea

Jan 30, 2026 11:41am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings